Friday, October 9, 2026 SourcesAbout🌓
🇨🇦 CA ▾
BREAKING
› World Aquatics Swimming World Cup: DAY 2 - Tashkent› Heliostar Metals to Present at the Precious Metals & Critical Minerals Virtual Investor Conference October 14› Copper Intelligence to Present at the Precious Metals & Critical Minerals Virtual Investor Conference October 13th› Navi Pillay, who accused Israel of genocide, wins Nobel Peace Prize› Health inspectors shut down Scarborough chicken shop over rodents› AZIO AI Signs First Hosting Agreement at Atlas One with Power Champion; 10 MW Contracted, with Expansion Rights to 50 MW Representing Up to Approximately $450 Million in Capacity Reservation Charges› TruGolf Completes Acquisition of Polymath Research, Bringing a Blockchain Purpose-Built for Regulated Assets to Nasdaq› Homes: When seeing a renovation is believing› U.S. bars Microsoft, Adobe and others from visa program› St. Eugene strikes right balance between difficult history and bright future› World Aquatics Swimming World Cup: DAY 2 - Tashkent› Heliostar Metals to Present at the Precious Metals & Critical Minerals Virtual Investor Conference October 14› Copper Intelligence to Present at the Precious Metals & Critical Minerals Virtual Investor Conference October 13th› Navi Pillay, who accused Israel of genocide, wins Nobel Peace Prize› Health inspectors shut down Scarborough chicken shop over rodents› AZIO AI Signs First Hosting Agreement at Atlas One with Power Champion; 10 MW Contracted, with Expansion Rights to 50 MW Representing Up to Approximately $450 Million in Capacity Reservation Charges› TruGolf Completes Acquisition of Polymath Research, Bringing a Blockchain Purpose-Built for Regulated Assets to Nasdaq› Homes: When seeing a renovation is believing› U.S. bars Microsoft, Adobe and others from visa program› St. Eugene strikes right balance between difficult history and bright future
Business

Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences

Financial Post ·

VANCOUVER, British Columbia, Oct.

09, 2026 (GLOBE NEWSWIRE) — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffus

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

More from Financial Post

See all ›

More in Business

See all ›